The TriMix-gel® Difference – NO NEEDLES
The difference between trimix injection and TriMix-gel® is “NO NEEDLE”. The active trimix ingredients have been lyophilized (dry freeze) into powder form. The powder is mixed with a medicated gel at time of use and then applied at the tip of the penis. There is no needle.
TriMix-gel® uses the same ingredients as trimix injection. The difference is the active ingredients have been lyophilized into powder form. The powder is mixed with a medicated gel at time of use and then applied at the tip of the penis. There is no needle.
TriMix-gel® doesn’t require needles because it uses a novel methodology. At time of use, the patient uses an “Easy Applicator System”™ application device that stores, mixes, and applies the medicine. The patient does not need a needle for self-injection and the medicine does not require refrigeration.
TriMix-gel® contains prescription medications listed in the U.S. Pharmacopoeia. The active ingredients are the vasodilators prostaglandin, papaverine, and phentolamine. A patient needs a doctor’s prescription. These ingredients have been tested and widely prescribed by physicians for the treatment of ED for many years.
TriMix-gel® does not have to be refrigerated. Therefore, the patient can carry the medicine on his person at room temperature. This characteristic is well received by mobile active patients because they report it helps promote spontaneity.
Most importantly, an ED patient will not have to use a needle to self-inject himself before sexual activity. Patients have reported the application of TriMix-gel® is quick and painless.
TriMix-gel® ingredients have also been shown to provide successful results when used in “combination therapy”. Urologists have prescribed PDE5s concomitantly with TriMix-gel® when both modalities have failed in monotherapy. The treatments use separate pathways which in combination has been reported to show successful results. There are several investigations in the medical literature suggesting combination therapy may be appropriate when each treatment has failed individually.
The identifying characteristics of TriMix-gel® are:
- Active ingredients: prostaglandin, papaverine, and phentolamine
- Easy Applicator System device which stores, mixes, and applies medicine
- Gel-based application of medicine
- Clinically tested
- Patient Trials published in The Journal of Urology Supplement, J. Urol. 179 (4): 431, 2008
- Presented at AUA World Conference Moderated Poster Session
- Easy to apply gel that has been used before sexual intercourse. Each dose contains trimix in powder form which is energized into a gel at time of use.
- Has been used for patients who fail on PDE5 Inhibitors or who cannot tolerate the side effects.
- Has been prescribed by urologists for ED patients who cannot not self-inject their own penis because of fear of needles.
- Combining PDE5 inhibitors and TriMix-gel® may be more effective where patients have failed with each treatment in monotherapy.
Men who find Viagra no longer helpful are aware of the superior results of penile injection therapy. But most men object to the thought of self-injection with a hypodermic needle into their own penis.
The patients who have failed on Viagra type tablets and who cannot bring themselves to self-inject their own penis with a hypodermic needle, have found TriMix-gel® a rewarding example of the value found in compounding pharmacy.
This is accomplished with a novel patented methodology (US patent numbers 9,005,183 and 9,968,479). At the time of use, before sexual activity, the patient uses an “Easy Applicator System™” application device that stores, mixes, and applies the medicine. THERE IS NO NEEDLE.
- TriMix-gel® does not have to be refrigerated. Therefore, the patient can carry the medicine on his person at room temperature. This is well received by mobile, active patients.
- TriMix-gel® uses a gel carrier, not a hard pellet placed one and one quarter inches into the urethra.
- TriMix-gel® does not require the patient to semi-self-catheterize himself with plastic device placed one and one quarter inches into the urethra.
- At the time of use, before sexual activity, the patient uses an innovative “All-In-One” application device that stores, mixes, and applies the medicine.
- And most importantly, before sexual activity, an ED patient will not have to use a hypodermic needle to self-inject his own penis. NO NEEDLE.
When Viagra Type Pills Don’t Work
Patients who don’t find Viagra type pills helpful or who can’t tolerate their side effects, TriMix-gel® has been viewed as an alternative before facing injection of their own penis with a hypodermic needle. With TriMix-gel®, THERE IS NO NEEDLE.
Medical Caution For Viagra Type Tablets
Some medical conditions require medications that are incompatible with the use of Viagra type pills which use PDE5 inhibitors. Viagra is contraindicated for medications such as nitrates and some hypertension medicines. The “Men’s Attitudes to Life Events and Sexuality Phase I” study indicated that 38% of men with hypertension also had ED. Men with diabetes or high blood pressure are disproportionally represented in the ED population increased probability of ED.
At Risk for ED
Risk for ED increases as men age. The prevalence of ED for men at age 40 is 39%, men at age 50 is 50%, men at age 60 is 60% and the prevalence for men at age 70 is 67%, according to data from the Massachusetts Male Aging Study. Today, approximately 30 million men in the U.S. have erectile dysfunction. Men with co-morbidities such as high blood pressure, heart disease, high cholesterol, and diabetes are disproportionably affected by ED.
Some of these conditions require medications that are incompatible with the use of PDE5s. The “Men’s Attitudes to Life Events and Sexuality Phase I” study indicated that 38% of men with hypertension also had ED. Men with diabetes or high blood pressure are disproportionably represented in the ED population increased probability of ED.
The multinational Men’s Attitudes to Life Events and Sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment-seeking patterns in men with erectile dysfunction
Eardley I et al, Int J Clin Pract. 2007 Sep;61(9):1446-53. Epub 2007 Jul 26 http://www.ncbi.nlm.nih.gov/pubmed/17655685?ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction?
Sun P et al, J Urol. 2005 Jul;174(1):244-8 at http://www.ncbi.nlm.nih.gov/pubmed/15947647?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Warning to Men: Erection Drugs Just Might Kill You
FDA Statement https://www.psychologytoday.com/blog/all-about-sex/201412/warning-men-erection-drugs-just-might-kill-you
Penile injection training
Duff E, McCullough A. Current Sexual Health Reports, Volume 3, Number 3 / September, 2006 found at https://link.springer.com/article/10.1007/s11930-006-0011-9
Pfizer Product Description, Chapter 7 http://labeling.pfizer.com/ShowLabeling.aspx?id=652 page 27